Banning all drug promotion is the best option pending major reforms.
Banning all drug promotion is the best option pending major reforms.
复制标题
DOI：
10.1007/bf02448846
复制
发表时间：
2005-01-01
影响因子：
2.4
通讯作者：
Mansfield, Peter R
中科院分区：
文献类型：
--
作者：
Mansfield, Peter R
应根据其对健康、获取信息、知情同意和财富的影响来评估药物推广。目前，药物促销对这些目标弊大于利，因为它通常具有误导性。这是一个系统性问题。虽然改善监管和教育将在一定程度上解决这个问题，但还需要对制药公司和医生的支付系统进行重大改革。在所有这些系统性改革到位之前，最好的政策选择是禁止向医生和公众推销药物。因此，在进行重大改革之前，各国政府应在政治上可以实现的范围内尽可能限制药物促销。
Drug promotion should be evaluated according to its impact on health, access to information, informed consent, and wealth. Drug promotion currently does more harm than good to each of these objectives because it is usually misleading. This is a systemic problem. Whilst improved regulation and education will address it to some degree, major reforms to payment systems for drug companies and doctors are also required. Until all these systemic reforms can be put in place, the best policy option is to ban the promotion of drugs to doctors and the public. Consequently, pending major reforms, it is appropriate for governments to restrict drug promotion as much as is politically achievable.